A recent study has shown that women with BRCA mutations are as likely to achieve local control with breast-conserving treatment as women without mutations, but have increased long-term risk of ipsilateral and contralateral breast cancer.
Related Articles
Featured
Use of PARP inhibitors in ovarian cancer
Patient Voice
Who should we screen for the BRCA gene?
Cutting Edge